🔎 Trials Near Me

Home › Degenerative Nerve Diseases › NCT07285954

Mindfulness Walking Intervention to Enhance Resilience (iWalk)

RecruitingHealthy volunteers welcome

A Randomized Controlled Trial of a Walking Meditation Intervention (iWalk) to Enhance Resilience in Adults

Who can join

Ages 18 to 110 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

1. 18 years or older,
2. clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
3. have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
4. never received meditation training via coaching/certification/life coaching,
5. have internet access,
6. with no severe cognitive impairment, i.e., have a score of ≥ 21 on Modified Telephonic Interview for Cognitive Status (TICS-M),
7. be able to walk with or without an assistive device (Patient determined Disease Steps score ranged from 0-6),
8. are willing to be randomized to an intervention or a control group,
9. are willing to wear Fitbit (a wrist smart watch) for eight weeks,
10. are individuals who are right-handed according to the Edinburgh Handedness Questionnaire,
11. are willing to participate in all assessments, including in-person testing using electroencephalography (EEG) and cognitive tests, online survey/questionnaires, and online interviews or focus group discussions,
12. are willing to wear a Hexoskin t-shirt, which is a heart rate variability monitor, while doing the assessments in person.

Exclusion Criteria:

Participants who cannot speak, read, write, or listen in English.

About the study

This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS).

The objectives are to evaluate:

1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.

What is being tested

Sponsor: University of Illinois at Urbana-Champaign · Participants: 90 · Started: Jun 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07285954

Locations in the U.S.

IllinoisUniversity of Illinois Urbana-Champaign, Urbana

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.